Human Longevity Stock
Genomics and cell therapy
Sign up today and learn more about Human Longevity Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Human Longevity Stock
Human Longevity, Inc. (HLI) is the genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived. HLI combines the largest database of genomic and phenotypic data with machine learning to drive discoveries and revolutionize the practice of medicine. HLI’s business areas include the HLI Health Nucleus, a genomic powered clinical research center which uses whole genome sequence analysis, advanced clinical imaging and innovative machine learning, along with curated personal health information, to deliver the most complete picture of individual health; HLIQ™ Whole Genome and HLIQ Oncology.
Co-Founder & CEO
Co-Founder & Vice Chairman
Chief Information Officer